Deutsche Bank’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$813K Sell
90,733
-115,489
-56% -$920K ﹤0.01% 2298
2025
Q4
$1.24M Buy
206,222
+3,118
+2% +$18.6K ﹤0.01% 2081
2025
Q3
$1.16M Buy
203,104
+7,609
+4% +$38.9K ﹤0.01% 2078
2025
Q2
$985K Sell
195,495
-12,795
-6% -$68.6K ﹤0.01% 2097
2025
Q1
$1.35M Sell
208,290
-8,444
-4% -$75.1K ﹤0.01% 1993
2024
Q4
$1.59M Buy
216,734
+27,515
+15% +$217K ﹤0.01% 1986
2024
Q3
$1.42M Buy
189,219
+143,182
+311% +$1.24M ﹤0.01% 1957
2024
Q2
$410K Buy
46,037
+4,572
+11% +$43.8K ﹤0.01% 2426
2024
Q1
$420K Buy
41,465
+4
+0% +$41 ﹤0.01% 2435
2023
Q4
$417K Sell
41,461
-1,015
-2% -$9.28K ﹤0.01% 2460
2023
Q3
$398K Buy
42,476
+5,219
+14% +$74.4K ﹤0.01% 2314
2023
Q2
$914K Sell
37,257
-76,950
-67% -$1.93M ﹤0.01% 2047
2023
Q1
$2.66M Sell
114,207
-28,880
-20% -$739K ﹤0.01% 1521
2022
Q4
$3.62M Buy
143,087
+103,692
+263% +$2.54M ﹤0.01% 1354
2022
Q3
$759K Sell
39,395
-3,845
-9% -$97.7K ﹤0.01% 2142
2022
Q2
$1.1M Sell
43,240
-1,238
-3% -$28.9K ﹤0.01% 2116
2022
Q1
$1.14M Sell
44,478
-3,748
-8% -$111K ﹤0.01% 2262
2021
Q4
$2.02M Sell
48,226
-1,676
-3% -$65.7K ﹤0.01% 1980
2021
Q3
$2.17M Buy
49,902
+2,762
+6% +$120K ﹤0.01% 2035
2021
Q2
$2.23M Buy
47,140
+5,310
+13% +$241K ﹤0.01% 2125
2021
Q1
$2.15M Sell
41,830
-3,898
-9% -$210K ﹤0.01% 2122
2020
Q4
$1.23M Buy
45,728
+14,925
+48% +$485K ﹤0.01% 2312
2020
Q3
$1.06M Buy
30,803
+7,410
+32% +$319K ﹤0.01% 2160
2020
Q2
$958K Buy
23,393
+20,902
+839% +$702K ﹤0.01% 2254
2020
Q1
$86K Sell
2,491
-320
-11% -$8.6K ﹤0.01% 3315
2019
Q4
$34K Buy
+2,811
New +$37.7K ﹤0.01% 4111

Other funds holding VIR